A detailed history of Champlain Investment Partners, LLC transactions in Penumbra Inc stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 1,547,972 shares of PEN stock, worth $372 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares
1,547,972
Previous 1,283,850 20.57%
Holding current value
$372 Million
Previous $231 Million 30.08%
% of portfolio
1.9%
Previous 1.46%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.64 - $210.12 $43.2 Million - $55.5 Million
264,122 Added 20.57%
1,547,972 $301 Million
Q2 2024

Aug 14, 2024

BUY
$172.27 - $223.95 $34.3 Million - $44.6 Million
199,255 Added 18.37%
1,283,850 $231 Million
Q1 2024

May 13, 2024

BUY
$220.09 - $273.15 $136 Million - $168 Million
616,700 Added 131.8%
1,084,595 $242 Million
Q4 2023

Feb 13, 2024

BUY
$181.44 - $260.22 $20.8 Million - $29.8 Million
114,505 Added 32.4%
467,895 $118 Million
Q3 2023

Nov 13, 2023

SELL
$240.69 - $338.77 $42.9 Million - $60.4 Million
-178,410 Reduced 33.55%
353,390 $85.5 Million
Q2 2023

Aug 11, 2023

SELL
$271.54 - $344.06 $26.2 Million - $33.2 Million
-96,475 Reduced 15.36%
531,800 $183 Million
Q1 2023

May 12, 2023

SELL
$220.43 - $278.69 $33.6 Million - $42.5 Million
-152,390 Reduced 19.52%
628,275 $175 Million
Q4 2022

Feb 13, 2023

SELL
$151.88 - $228.5 $3.56 Million - $5.35 Million
-23,410 Reduced 2.91%
780,665 $173 Million
Q3 2022

Nov 14, 2022

BUY
$120.36 - $205.88 $23.5 Million - $40.3 Million
195,635 Added 32.15%
804,075 $152 Million
Q2 2022

Aug 12, 2022

BUY
$116.09 - $227.33 $15.5 Million - $30.4 Million
133,720 Added 28.17%
608,440 $75.8 Million
Q1 2022

May 12, 2022

BUY
$187.51 - $283.98 $738,789 - $1.12 Million
3,940 Added 0.84%
474,720 $105 Million
Q4 2021

Feb 10, 2022

BUY
$238.08 - $288.0 $8.14 Million - $9.85 Million
34,195 Added 7.83%
470,780 $135 Million
Q3 2021

Nov 12, 2021

BUY
$250.72 - $291.24 $555,344 - $645,096
2,215 Added 0.51%
436,585 $116 Million
Q2 2021

Aug 12, 2021

BUY
$235.0 - $310.7 $849,525 - $1.12 Million
3,615 Added 0.84%
434,370 $119 Million
Q1 2021

May 13, 2021

SELL
$175.6 - $291.43 $6.56 Million - $10.9 Million
-37,340 Reduced 7.98%
430,755 $117 Million
Q4 2020

Feb 12, 2021

BUY
$174.98 - $272.83 $12 Million - $18.7 Million
68,485 Added 17.14%
468,095 $81.9 Million
Q3 2020

Nov 13, 2020

SELL
$185.27 - $238.73 $591,011 - $761,548
-3,190 Reduced 0.79%
399,610 $77.7 Million
Q2 2020

Aug 13, 2020

BUY
$153.32 - $191.72 $12 Million - $15 Million
78,140 Added 24.07%
402,800 $72 Million
Q1 2020

May 14, 2020

BUY
$124.34 - $193.76 $6.84 Million - $10.7 Million
55,035 Added 20.41%
324,660 $52.4 Million
Q4 2019

Feb 13, 2020

BUY
$134.81 - $177.8 $3.27 Million - $4.31 Million
24,255 Added 9.89%
269,625 $44.3 Million
Q3 2019

Nov 14, 2019

BUY
$131.82 - $183.4 $7.52 Million - $10.5 Million
57,045 Added 30.29%
245,370 $33 Million
Q2 2019

Aug 13, 2019

SELL
$124.65 - $167.39 $183,235 - $246,063
-1,470 Reduced 0.77%
188,325 $30.1 Million
Q1 2019

May 14, 2019

SELL
$115.84 - $160.31 $13.7 Million - $18.9 Million
-117,835 Reduced 38.3%
189,795 $27.9 Million
Q4 2018

Feb 13, 2019

SELL
$113.42 - $156.48 $17 Million - $23.4 Million
-149,825 Reduced 32.75%
307,630 $37.6 Million
Q3 2018

Nov 13, 2018

BUY
$121.55 - $156.8 $15.5 Million - $20 Million
127,865 Added 38.8%
457,455 $68.5 Million
Q2 2018

Aug 13, 2018

SELL
$112.2 - $165.95 $7.25 Million - $10.7 Million
-64,620 Reduced 16.39%
329,590 $45.5 Million
Q1 2018

May 14, 2018

SELL
$84.6 - $126.1 $179,352 - $267,332
-2,120 Reduced 0.53%
394,210 $45.6 Million
Q4 2017

Feb 12, 2018

SELL
$91.55 - $115.85 $4.82 Million - $6.1 Million
-52,655 Reduced 11.73%
396,330 $37.3 Million
Q3 2017

Nov 13, 2017

BUY
$79.65 - $90.3 $35.8 Million - $40.5 Million
448,985
448,985 $40.5 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Champlain Investment Partners, LLC Portfolio

Follow Champlain Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.